About Fisher Wallace Laboratories
Fisher Wallace Laboratories is a private company based in Brooklyn, New York. It has reported $250,000 raised in two offerings on Form D since July 2022. Its chief executive is Kelly Roman.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | Jun 13, 2025 | $0of $5.0M target | 0 | — | EquityRule 506(c) | Form D ↗ |
| Jul 3, 2022 | Jul 26, 2022 | $250,000of $750K target | 1 | $250K | Debt, OptionsRule 506(c) | Form D ↗ |
| Total, two offerings | $250,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Fisher Wallace Laboratories's Form D filed Jun 13, 2025.
KR
Kelly Roman
CEO and director
CF
Charles Fisher
Director
Earlier filings also listed Simon Webster (director, last listed Jul 2022).